4D Molecular Therapeutics
FDMT
#8752
Rank
C$0.16 B
Marketcap
$3.59
Share price
-4.72%
Change (1 day)
-90.82%
Change (1 year)

4D Molecular Therapeutics (FDMT) - Cash on Hand

Cash on Hand as of December 2024 : C$0.60 Billion

According to 4D Molecular Therapeutics's latest financial reports the company has C$0.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

4D Molecular Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.60 B59.48%
2023-12-31C$0.38 B31.93%
2022-12-31C$0.28 B-8.23%
2021-12-31C$0.31 B-10.51%
2020-12-31C$0.35 B444.11%
2019-12-31C$64.84 M-48.12%
2018-12-31C$0.12 B316.86%
2017-12-31C$29.98 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.36 B-39.76%๐Ÿ‡บ๐Ÿ‡ธ USA